To investigate whether Fpr2 was associated with the sex disparities in CDAHFD-induced NAFLD, Fpr2-deficient (KO) mice were treated with CDAHFD. The gene discussed is FPR2; the disease is metabolic dysfunction-associated steatotic liver disease.